Emerging engineered magnetic nanoparticulate probes for molecular MRI of atherosclerosis : how far have we come?
Kanwar, Rupinder K., Chaudhary, Rajneesh, Tsuzuki, Takuya and Kanwar, Jagat R. 2012, Emerging engineered magnetic nanoparticulate probes for molecular MRI of atherosclerosis : how far have we come?, Nanomedicine, vol. 7, no. 6, pp. 899-916.
Attached Files
(Some files may be inaccessible until you login with your Deakin Research Online credentials)
Name
Description
MIMEType
Size
Downloads
Title
Emerging engineered magnetic nanoparticulate probes for molecular MRI of atherosclerosis : how far have we come?
Atherosclerosis is a chronic, progressive, immunoinflammatory disease of the large and medium-sized arteries, and a major cause of cardiovascular diseases. Atherosclerosis often progresses silently for decades until the occurrence of a major catastrophic clinical event such as myocardial infarction, cardiac arrest and stroke. The main challenge in the diagnosis and management of atherosclerosis is to develop a safe, noninvasive technique that is accurate and reproducible, which can detect the biologically active high-risk vulnerable plaques (with ongoing active inflammation, angiogenesis and apoptosis) before the occurrence of an acute clinical event. This Journal Article reviews the events involved in the pathogenesis of atherosclerosis in light of recently advanced understanding of the molecular pathogenesis of the disease. Next, we elaborate on the interesting developments in molecular MRI, by describing the recently engineered magnetic nanoparticulate probes targeting clinically promising molecular and cellular players/processes, involved in early atherosclerotic lesion formation to plaque rupture and erosion.
Language
eng
Field of Research
119999 Medical and Health Sciences not elsewhere classified
Socio Economic Objective
970111 Expanding Knowledge in the Medical and Health Sciences